Puregraf 150 IU Injection

What is Puregraf 150 IU?

Puregraf 150 IU is a specialized injectable medication designed to address female infertility issues. It contains the active ingredient Menotrophin, which is a blend of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones play a crucial role in stimulating ovarian follicle development and ovulation. Manufactured by Gufic Biosciences Ltd., this product is trusted worldwide for its quality and efficacy.

In particular, Puregraf 150 IU is formulated to aid women who face challenges with natural conception due to hormonal imbalances or other reproductive conditions. This makes it a vital option in fertility treatments, especially when other methods have not been successful. Patients in the UK and Canada find this medication to be a valuable support in their journey toward parenthood.

Uses of Puregraf 150 IU

• Treatment of female infertility caused by anovulation or oligo-ovulation disorders
• Stimulation of follicle development in women undergoing assisted reproductive technologies (ART) such as IVF
• Helping patients who have insufficient endogenous gonadotropin secretion
• Supporting ovulation induction when clomiphene citrate therapy has proven ineffective

How Puregraf 150 IU Works

Puregraf 150 IU works by providing exogenous Menotrophin, which essentially mimics the body’s natural reproductive hormones FSH and LH. These hormones induce the growth and maturation of ovarian follicles the tiny sacs that contain eggs ready for fertilization. By stimulating folliculogenesis, Puregraf 150 IU promotes ovulation, increasing the chances of conception.

The balance between FSH and LH is vital for the normal menstrual cycle. When the body’s production is inadequate, Puregraf supplies the needed hormonal signals to jump-start the ovulatory process. This mechanism makes it especially useful in clinical fertility treatments where hormonal regulation is crucial.

Benefits of Puregraf 150 IU

• Effectively induces ovulation in women with infertility issues
• Supports follicular development in various fertility treatment protocols
• Formulated with purified Menotrophin ensuring precise hormone delivery
• Manufactured by a reputable company, ensuring safety and quality standards
• Can be used in combination with assisted reproductive technologies for enhanced results

Dosage and Administration

Puregraf 150 IU should be administered strictly under medical supervision. The dosage varies depending on the patient’s specific condition, response to treatment, and the physician’s assessment. Typically, an initial dose is given by subcutaneous or intramuscular injection early in the menstrual cycle to encourage follicle growth.

Regular monitoring through ultrasound and hormone blood tests is necessary to adjust the dose and avoid complications such as ovarian hyperstimulation syndrome (OHSS). Follow your healthcare provider’s instructions carefully for the duration and frequency of injections.

Available Strength

• Puregraf 75 IU

Who Should Use Puregraf 150 IU?

Puregraf 150 IU is recommended for women diagnosed with infertility due to disrupted ovulation or inadequate gonadotropin production. It is especially suitable for those who have not responded well to first-line treatments like clomiphene citrate. Women participating in fertility clinics or reproductive assistance programs can benefit from its clinical effectiveness.

Who Should Avoid Puregraf 150 IU?

Patients with certain conditions should avoid using Puregraf 150 IU. These include those with:

• Ovarian cysts not related to infertility
• Unexplained uterine bleeding
• Hypersensitivity to Menotrophin or any excipients in the formulation
• Hormone-sensitive cancers
• Gynecological tumors or ovarian enlargement without clear cause

Always inform your doctor about your full medical history before starting treatment.

Side Effects

• Ovarian Hyperstimulation Syndrome (OHSS): Symptoms can include abdominal pain, swelling, nausea, and rapid weight gain. It requires immediate medical attention.
• Injection site reactions: Mild pain, redness, or swelling may occur at the injection site.
• Headache and fatigue: Some users report mild to moderate headaches and tiredness.
• Abdominal discomfort: Cramping or bloating can occasionally happen during treatment.
• Allergic reactions: Though rare, skin rash, itching, or breathing difficulties need urgent care.

Safety Advice

• Use Puregraf 150 IU only as prescribed by a qualified healthcare professional.
• Do not self-administer injections without proper training.
• Report any unusual symptoms such as severe abdominal pain or swelling immediately.
• Monitor for signs of OHSS during and after the treatment period.
• Avoid using Puregraf 150 IU if pregnant or breastfeeding unless advised otherwise by your doctor.
• Keep all scheduled appointments for monitoring hormone levels and follicle development.

Drug Interactions

• Coadministration with other ovarian stimulants should be carefully controlled to prevent overdose effects.
• Concurrent use of hormone therapies may alter the drug’s effectiveness.
• Always inform your healthcare provider about any other medications or supplements you are taking.

Storage Instructions

Store Puregraf 150 IU injection in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the vial in its original packaging to protect it from light. Before use, allow it to reach room temperature but do not warm it by any artificial means. Use the product before the expiry date marked on the packaging.

Where to buy Puregraf 150 IU in UK?

If you are looking to buy Puregraf 150 IU in the UK, it is advised to obtain it through licensed pharmacies and reputable online medical ( MedzSite ) suppliers. Always ensure the product is sourced legitimately to guarantee authenticity and safety. Consulting a fertility specialist will help secure the correct prescription and dosage tailored to your needs.

Frequently Asked Questions (FAQ)

How long does it take for Puregraf 150 IU to work?

Generally, ovulation is stimulated within 7 to 14 days after starting the injections, but this can vary depending on individual response and treatment protocol.

What should I do if Puregraf 150 IU does not work?

If you do not respond to Puregraf 150 IU, discuss alternative fertility treatments with your doctor. Sometimes adjusting the dose or combining with other therapies can help.

What is the price of Puregraf 150 IU in the UK?

Prices vary depending on the supplier and whether it is bought through a clinic or pharmacy. It’s best to consult official sources or pharmacies for accurate current pricing.

Is Puregraf 150 IU safe for older adults?

Use in older women should be carefully evaluated by a doctor, considering overall health and reproductive goals. Safety is determined on an individual basis.

What happens if I miss a dose?

Contact your healthcare provider immediately for guidance. Do not double the next dose without professional advice as it may increase side effects.

Can side effects be prevented?

Regular monitoring and following your doctor’s instructions reduce risks. Promptly reporting side effects can help manage them effectively.

Is it safe for daily use?

Puregraf 150 IU is typically not used daily but administered as per individualized medical regimens designed by fertility specialists.

When should I avoid using Puregraf 150 IU?

Avoid it if you have conditions like ovarian cysts, unexplained bleeding, or allergies to the drug components. Always consult your doctor before starting treatment.

Conclusion

Puregraf 150 IU is a valuable medication in the management of female infertility, particularly useful for stimulating ovulation in women with hormonal imbalances. With its active ingredient Menotrophin produced by Gufic Biosciences Ltd., it offers an effective option within assisted reproductive technologies. Careful administration under medical supervision ensures the best possible outcomes while managing risks. For patients in the UK and Canada seeking professional fertility support, Puregraf 150 IU represents a promising step toward achieving pregnancy.